Evidence map›Paper›PMID 34825871›Full record

ArticleCurrent Alzheimer research2021

Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD.

Annie G Bryant, Mary K Manhard, David H Salat, Bruce R Rosen, Bradley T Hyman, Keith A Johnson, Susie Huang, Rachel E Bennett, Yi-Fen Yen

Open access · greenAbstract read
In one paragraph

Article in Current Alzheimer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Frontiers in global women's health · 2025
    Article
  3. Review
  4. Review
  5. Aberrant vascular architecture in the hippocampus correlates with tau burden in mild cognitive impairment and Alzheimer's disease.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Annie G BryantDepartment of Neurology, Harvard Medical School, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, MA,United States.
Mary K ManhardDepartment of Radiology, Massachusetts General Hospital, Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA,United States.
David H SalatDepartment of Radiology, Massachusetts General Hospital, Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA,United States.
Bruce R RosenDepartment of Radiology, Massachusetts General Hospital, Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA,United States.
Bradley T HymanDepartment of Neurology, Harvard Medical School, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, MA,United States.
Keith A JohnsonDepartment of Neurology, Harvard Medical School, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, MA,United States.
Susie HuangDepartment of Radiology, Massachusetts General Hospital, Athinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA,United States.
Rachel E BennettDepartment of Neurology, Harvard Medical School, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, MA,United States.
Yi-Fen YenDepartment of Neurology, Harvard Medical School, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Charlestown, MA,United States.
Athinoula A. Martinos Center for Biomedical Imaging · USMaineGeneral Medical Center · USMassachusetts General Hospital · USHarvard University · US

Funding

Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Sudeshna Das · 2019 to 2026
$36.5M
Training and Dissemination CoreP41EB030006 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI Susie Yi Huang · 2020 to 2026
$10.9M
Assessing the Functional Consequences of Tau-Related Vasculature Changes using In Vivo ImagingR00AG061259 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI BENNETT, RACHEL ELISE · 2021 to 2023
$747k
Exploring the Relationship Between Tau Deposition and Neurovascular Health in Alzheimer's DiseaseR21AG067562 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HUANG, SUSIE YI, YEN, YI-FEN · 2020 to 2020
$462k
Assessing the Functional Consequences of Tau-Related Vasculature Changes using In Vivo ImagingK99AG061259 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI BENNETT, RACHEL ELISE · 2019 to 2020
$271k
NIA NIH HHS K99 AG061259NIA NIH HHS P30 AG062421NIA NIH HHS R00 AG061259NIA NIH HHS R21 AG067562NIBIB NIH HHS P41 EB030006NIH HHS P41EB030006, R21AG067562, K99AG061259, P30AG062421
6 · The paper itself

Abstract

backgroundReduced cerebrovascular function and accumulation of tau pathology are key components of cognitive decline in Alzheimer's disease (AD). Recent multimodal neuroimaging studies show a correlation between cortical tau accumulation and reduced cerebral perfusion. However, animal models predict that tau exerts capillary-level changes that may not be fully captured by standard imaging protocols.

objectiveUsing newly-developed magnetic resonance imaging (MRI) technology to measure capillary- specific perfusion parameters, we examined a series of mild cognitive impairment (MCI) and AD patients with tau positron emission tomography (PET) to observe whole-brain capillary perfusion alterations and their association with tau deposition.

methodsSeven subjects with MCI or AD received Flortaucipir PET to measure tau deposition and spin-echo dynamic susceptibility contrast (SE-DSC) MRI to measure microvascular perfusion (<10μm radius vessels). Gradient-echo (GE) DSC and pseudocontinuous arterial spin labeling (PCASL) MRI were also acquired to assess macrovascular perfusion. Tau PET, microvascular perfusion, and cortical thickness maps were visually inspected in volumetric slices and on cortical surface projections.

resultsHigh tau PET signal was generally observed in the lateral temporal and parietal cortices, with uptake in the occipital cortex in one subject. Global blood flow measured by PCASL was reduced with increasing tau burden, which was consistent with previous studies. Tau accumulation was spatially associated with variable patterns of microvascular cerebral blood flow (CBF) and oxygen extraction fraction (OEF) in the cortex and with increased capillary transit heterogeneity (CTH) in adjacent periventricular white matter, independent of amyloid-β status.

conclusionAlthough macrovascular perfusion generally correlated with tau deposition at the whole-cortex level, regional changes in microvascular perfusion were not uniformly associated with either tau pathology or cortical atrophy. This work highlights the heterogeneity of AD-related brain changes and the challenges of implementing therapeutic interventions to improve cerebrovascular function.

Indexed as

Alzheimer DiseaseCognitive DysfunctionAmyloid beta-PeptidesHumansMagnetic Resonance ImagingPositron-Emission Tomographytau ProteinsAmyloid beta-Peptidestau ProteinsAlzheimer's diseasecerebrovascular function.dynamic susceptibility contrast magnetic resonance imagingmicrovascular perfusionmultimodal neuroimagingpositron emission tomographytau pathology

Identifiers

PMID34825871
PMCPMC8822690
OpenAlexW3216201924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.